Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2001 1
2002 12
2003 10
2004 13
2005 19
2006 23
2007 15
2008 15
2009 18
2010 13
2011 9
2012 15
2013 6
2014 6
2015 6
2016 2
2017 5
2018 3
2019 2
2020 4
2021 3
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Sepsis expands a CD39+ plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity.
Nascimento DC, Viacava PR, Ferreira RG, Damaceno MA, Piñeros AR, Melo PH, Donate PB, Toller-Kawahisa JE, Zoppi D, Veras FP, Peres RS, Menezes-Silva L, Caetité D, Oliveira AER, Castro ÍMS, Kauffenstein G, Nakaya HI, Borges MC, Zamboni DS, Fonseca DM, Paschoal JAR, Cunha TM, Quesniaux V, Linden J, Cunha FQ, Ryffel B, Alves-Filho JC. Nascimento DC, et al. Among authors: linden j. Immunity. 2021 Sep 14;54(9):2024-2041.e8. doi: 10.1016/j.immuni.2021.08.005. Epub 2021 Sep 1. Immunity. 2021. PMID: 34473957 Free article.
Unlocking antitumor immunity with adenosine receptor blockers.
Remley VA, Linden J, Bauer TW, Dimastromatteo J. Remley VA, et al. Among authors: linden j. Cancer Drug Resist. 2023 Oct 25;6(4):748-767. doi: 10.20517/cdr.2023.63. eCollection 2023. Cancer Drug Resist. 2023. PMID: 38263981 Free PMC article. Review.
Purinergic regulation of the immune system.
Cekic C, Linden J. Cekic C, et al. Among authors: linden j. Nat Rev Immunol. 2016 Mar;16(3):177-92. doi: 10.1038/nri.2016.4. Nat Rev Immunol. 2016. PMID: 26922909 Review.
Pharmacology of purine and pyrimidine receptors. Preface.
Jacobson KA, Linden J. Jacobson KA, et al. Among authors: linden j. Adv Pharmacol. 2011;61:xv-xvi. doi: 10.1016/B978-0-12-385526-8.00020-5. Adv Pharmacol. 2011. PMID: 21586353 No abstract available.
Regulation of lymphocyte function by adenosine.
Linden J, Cekic C. Linden J, et al. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2097-103. doi: 10.1161/ATVBAHA.111.226837. Epub 2012 Jul 5. Arterioscler Thromb Vasc Biol. 2012. PMID: 22772752 Free PMC article. Review.
The role of adenosine signaling in sickle cell therapeutics.
Field JJ, Nathan DG, Linden J. Field JJ, et al. Among authors: linden j. Hematol Oncol Clin North Am. 2014 Apr;28(2):287-99. doi: 10.1016/j.hoc.2013.11.003. Epub 2014 Jan 18. Hematol Oncol Clin North Am. 2014. PMID: 24589267 Free PMC article. Review.
Purinergic regulation of epithelial transport.
Bucheimer RE, Linden J. Bucheimer RE, et al. Among authors: linden j. J Physiol. 2004 Mar 1;555(Pt 2):311-21. doi: 10.1113/jphysiol.2003.056697. Epub 2003 Dec 23. J Physiol. 2004. PMID: 14694149 Free PMC article. Review.
Targeting iNKT cells for the treatment of sickle cell disease.
Field JJ, Nathan DG, Linden J. Field JJ, et al. Among authors: linden j. Clin Immunol. 2011 Aug;140(2):177-83. doi: 10.1016/j.clim.2011.03.002. Epub 2011 Mar 22. Clin Immunol. 2011. PMID: 21429807 Free PMC article. Review.
187 results